Research article  

Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study

Deirdre P Cronin-Fenton, Lars Pedersen, Timothy L Lash, Søren Friis, John A Baron, Henrik T Sørensen Breast Cancer Research 2010, 12:R15 (1 March 2010)

Abstract | Full text | PDF | PubMed

Research article  

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

Silvia Darb-Esfahani, Sibylle Loibl, Berit M Müller, Marc Roller, Carsten Denkert, Martina Komor, Karsten Schlüns, Jens Uwe Blohmer, Jan Budczies, Bernd Gerber, Aurelia Noske, Andreas du Bois, Wilko Weichert, Christian Jackisch, Manfred Dietel, Klaus Richter, Manfred Kaufmann, Gunter von Minckwitz Breast Cancer Research 2009, 11:R69 (16 September 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article  

Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis

Johanna R Reed, Ronald P Leon, Majken K Hall, Kathryn L Schwertfeger Breast Cancer Research 2009, 11:R21 (24 April 2009)

Abstract | Full text | PDF | PubMed

Research article  

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study

Gretchen L Gierach, James V Lacey, Arthur Schatzkin, Michael F Leitzmann, Douglas Richesson, Albert R Hollenbeck, Louise A Brinton Breast Cancer Research 2008, 10:R38 (30 April 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | Editor’s summary